Latest Articles
Lena Dunham reveals she's 'in the process of expanding our family' with her husband after endometriosis battle and a hysterectomy - Nine - Honey
Lena Dunham reveals she's 'in the process of expanding our family' with her husband after endometriosis battle and a hysterectomy Nine - Honey
Published: July 2, 2025, 10:23 p.m.
VisualAbstract: Lactated Ringer’s Solution Does Not Improve Outcomes Relative to Normal Saline - 2 Minute Medicine
VisualAbstract: Lactated Ringer’s Solution Does Not Improve Outcomes Relative to Normal Saline 2 Minute Medicine
Published: July 2, 2025, 7:18 p.m.
Organon’s endometriosis drug discontinued after failing to improve pain - PharmaLive
Organon’s endometriosis drug discontinued after failing to improve pain PharmaLive
Published: July 2, 2025, 6:39 p.m.
Microsoft Layoffs Reportedly Trigger Cancellation Of Long-Running Gaming Projects, Scaled-Back AI Chip Plans - Stocktwits
Microsoft Layoffs Reportedly Trigger Cancellation Of Long-Running Gaming Projects, Scaled-Back AI Chip Plans Stocktwits
Published: July 2, 2025, 5:05 p.m.
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications - TipRanks
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications TipRanks
Published: July 2, 2025, 5:03 p.m.
Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain - BioSpace
Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain BioSpace
Published: July 2, 2025, 2:08 p.m.
Women with endometriosis-associated infertility are more likely to become pregnant, study reveals - News-Medical
Women with endometriosis-associated infertility are more likely to become pregnant, study reveals News-Medical
Published: July 2, 2025, 1:30 p.m.
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain - MarketScreener
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain MarketScreener
Published: July 2, 2025, 12:51 p.m.
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener
Published: July 2, 2025, 12:10 p.m.
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program - TipRanks
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program TipRanks
Published: July 2, 2025, 11:54 a.m.
Link copied to clipboard!